The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation ; volume:23 ; number:1 ; day:18 ; month:12 ; year:2023 ; pages:1-18 ; date:12.2023
Cancer cell international ; 23, Heft 1 (18.12.2023), 1-18, 12.2023
- Creator
-
Chu, Gerard J.
Bailey, Charles G.
Nagarajah, Rajini
Sagnella, Sharon M.
Adelstein, Stephen
Rasko, John E. J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-03171-7
- URN
-
urn:nbn:de:101:1-2024030220591225823185
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chu, Gerard J.
- Bailey, Charles G.
- Nagarajah, Rajini
- Sagnella, Sharon M.
- Adelstein, Stephen
- Rasko, John E. J.
- SpringerLink (Online service)
Other Objects (12)
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Chimeric Antigen Receptor T-Cell Therapy
Empowering gamma delta T‐cell functionality with vitamin C : = Empowering γδ T‐cell functionality with vitamin C
Empowering γδ T‐cell functionality with vitamin C
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
The effects of the costimulatory Ox40-Ox40Ligand interaction on monoclonal T-cell responses
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Chimeric Antigen Receptor T-Cell Therapy
Empowering gamma delta T‐cell functionality with vitamin C : = Empowering γδ T‐cell functionality with vitamin C
Empowering γδ T‐cell functionality with vitamin C
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
The effects of the costimulatory Ox40-Ox40Ligand interaction on monoclonal T-cell responses
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Chimeric Antigen Receptor T-Cell Therapy
Empowering gamma delta T‐cell functionality with vitamin C : = Empowering γδ T‐cell functionality with vitamin C
Empowering γδ T‐cell functionality with vitamin C
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
The effects of the costimulatory Ox40-Ox40Ligand interaction on monoclonal T-cell responses
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells